Trial intelligence / Profile preview

Initial oxygen concentration for resuscitation of extremely preterm neonates

2011-005717-36Phase 3Terminated

Sponsor
Health Research Institute Hospital La Fe
Start
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of oxygen in preterm birth and hypopnea (2 arms), sponsored by Health Research Institute Hospital La Fe. Primary endpoint: Survival without bronchopulmonary dysplasia. Started Mar 2012; status: terminated.

02

Drugs

oxygen
03

Conditions

preterm birthhypopnea

Beyond the preview

Go deeper on 2011-005717-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-005717-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call